Anteris Technologies Ltd

ASX AVR.AX

Anteris Technologies Ltd Market Capitalization on January 14, 2025: USD 215.79 M

Anteris Technologies Ltd Market Capitalization is USD 215.79 M on January 14, 2025, a -5.16% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Anteris Technologies Ltd 52-week high Market Capitalization is USD 283.33 M on April 04, 2024, which is 31.30% above the current Market Capitalization.
Anteris Technologies Ltd 52-week low Market Capitalization is USD 120.06 M on November 14, 2024, which is -44.36% below the current Market Capitalization.
Anteris Technologies Ltd average Market Capitalization for the last 52 weeks is USD 203.24 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

ASX: AVR.AX

Anteris Technologies Ltd

CEO	Mr. Wayne Geoffrey Paterson
IPO Date	March 22, 2004
Location	Australia
Headquarters	Toowong Tower
Employees	1
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Key trends

Past 5 years